MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

Center Information

John Hunter, PsyD
Clinic Administrator
MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute
8550 Marshall Dr. Suite 100
Lenexa, KS 66214
913-647-0296 (fax)
View Map

Contact Center

Currently Enrolling Trials

[Show More]

Therapeutic Areas


Center Overview

Rowe Neurology Institute, a clinical practice in Neurology, was founded in 1982 by Vernon D. Rowe III, MD. When a need was seen to provide comprehensive medical care, with a bench to bedside philosophy, the MidAmerica Neuroscience Research Foundation (MANRF) was formed. MANRF is a nonprofit research organization with both basic science and clinical research interests. The Rowe Neurology Institute clinical research program is comprised of 4 neurologists, a neuropsychologist, 2 advanced practice nurses and 4 clinical research coordinators. RNI/MANRF conducts research with the highest standards, according to FDA regulations and Good Clinical Practice. All of our research professionals maintain certification in the protection of human subjects through CITI (Collaborative Institutional Training Initiative).

Performance Metrics

Number of Studies Actually Completed: 50+
Regulatory Submission Turn-Around Time: 2 Week(s)
EDC Capabilities: Yes

Clinical Research Experience

RNI/MANRF conducts principal investigator initiated research and sponsored clinical trials. We have extensive experience and areas of excellence in the following areas:

  • Multiple Sclerosis
  • Migraine and Headache
  • Sleep Disorders
  • Restless Leg Syndrome
  • Alzheimer's Disease
  • Memory Disorders

We have worked with the following sponsors and contract research organizations:

  • AAI Pharma/Janssen
  • Abbott
  • Astra Zeneca International
  • Actelion
  • Berlex Laboratories
  • Biogen Idec
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Cognition Pharmaceuticals LLC
  • Covance
  • Eisai
  • Genomics Collaborative
  • GlaxoSmithKline
  • i3 Research
  • Icon Clinical Research
  • Impax Laboratories, Inc.
  • INC Research
  • Janssen
  • Kendle International, Inc.
  • Luitpold Pharmaceuticals
  • MDS Pharma Services
  • Merck & Co, Inc.
  • Novartis Pharmaceuticals
  • Opexa Therapeutics
  • PRA International
  • Premier Research
  • Pfizer
  • PPD, Inc.
  • Quintiles, Inc.
  • Roche
  • Serono
  • Schwarz Pharma
  • SunPharma
  • Takeda Pharmaceuticals
  • Teva NeuroScience
  • TorreyPines Therapeutics
  • UCB Pharma Inc.
  • Xenoport, Inc.
  • Yamanouchi Pharma Ltd.

Facility Description

The RNI Research program is embedded within the clinical neurology practice of Rowe Neurology Institute allowing the seamless delivery of cutting edge treatment options to our neurological patients. In addition, it enables our physicians to provide direct oversight, ensuring our clinical trials are completed accurately with patient safety as a priority.

RNI/MANRF is located in Lenexa, Kansas toward the southwest corner of the Kansas City Metropolitan area. The 15-county Kansas City Metropolitan area is the 27th largest in the United States with an estimated population of 1,967,405. The research program is a handicap accessible medical clinic well equipped and conveniently located near major highways, and approximately 30 minutes from an international airport. The Institute operates its own imaging center, neurophysiology lab, state of the art polysomnography sleep lab, physical therapy center, and clinical and basic science research area.

The Sleep center is accredited by the American Academy of Sleep Medicine. The center has 8 sleep beds, digital equipment. The staff includesFive registeredpolysomnography technologists, two of whom are certified Respiratory Therapists.

The clinical research area consists of examination rooms; double-locking, limited-access medication storage (room temperature, refrigerated and -20 °); draw/processing laboratory with dedicated sample storage units (room temperature, refrigerated, -20 ° and -70 °); ECG equipment; radiology facilities (X-ray, MRI, CT); emergency protocols (crash cart, local ER facilities); and high-speed Internet access to support Electronic Data Capture activities and dedicated monitor space with Internet connectivity.

Facility details include:
17 exam rooms, 8 sleep rooms, 2 infusion rooms, Imaging Center, OTC, as well as a physical therapy gym

Investigator Experience

Our team of experienced investigators, coordinators, and administrative professionals bring knowledge, skill, quality, and a commitment to the research participant in every research trial in which we participate. Our investigators include:

Vernon D. Rowe III, MD

  • CEO and Founder of MidAmerica Neuroscience Research Foundation
  • Board certified in Neurology and Sleep Medicine plus 3 other Boards
  • Licensed in Missouri, Kansas, and North Carolina
  • Clinical trial specialties include Multiple Sclerosis, and Sleep Disorders

Dana M. Winegarner, DO

  • Joined the institute in 2001
  • Has served as primary investigator on 15+ clinical trials
  • Licensed in Missouri and Kansas
  • Clinical trial specialties include Migraine Headaches, and Dementia Disorders

Kenneth VanOwen, MD

  • Joined the institute in 2012
  • Board certified in Neurology, Sleep Medicine, and Clinical Neurophysiology
  • Licensed in Missouri and Kansas

George R. Moreng, MD

  • Director of the Imaging Center for Rowe Neurology Institute since 1983
  • Licensed in Missouri and Kansas

Amelia Winsby, Ph.D.

  • Joined the institute in 2015
  • Practices Clinical Neuropsychology
  • Licensed in Missouri and Kansas
  • Performs neuropsychological evaluations for clinical research trials

Staff Expertise

John Hunter, Psy.D.

  • Executive director of the Rowe Neurology Instiutute / MANRF
  • Over 15 years of clinical research experience

Leigh Kreshel, MS, CCRC

  • 12 years of clinical research experience
  • Maintains certification through ACRP
  • Coordinated 20+ clinical research trials

LeAnn Cannon, LPN, CCRC

  • 13 years of clinical research experience
  • Maintains certification through ACRP as well as SOCRA
  • Coordinated 20+ clinical research trials

Shannon Cone, LPN

  • 15 years of clinical research experience
  • Coordinated 50+ clinical research trials

Leah Kemble, BA

  • 2 years clinical research experience
  • Patient recruitment specialist
  • Regulatory specialist

Other Information

The research foundation at MidAmerica Neuroscience Research Foundation uses a central IRB. The turn-around time in submitting all regulatory documentation averages 2 - 7 days. We accomplish the regulatory process in approximately two weeks with expedited completion possible. Contract budgets typically finalized within a week.

As our research studies in neurology are constantly changing, for the most accurate information on our currently-enrolling clinical studies and to find out if you qualify, please fill out the form found here.

Contact Center

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the email form below. A representative from the research center will then follow up with you.